文献速递肺外科

临床IA期肺癌楔形切除应同期行淋巴结清扫

The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

该回顾性研究纳入196例接受楔形切除的周围型临床IA期非小细胞肺癌患者,其中138例(70%)清扫淋巴结(中位4枚),58例(30%)未清扫。淋巴结清扫组5年无局部区域复发率显著更高(92% vs 74%,P=0.025),倾向评分匹配后结论一致,且未增加并发症或住院时间。

要点

  • 楔形切除同期淋巴结清扫不增加手术时间、出血、胸管留置或住院时间。
  • 临床IA期楔形切除患者中4.3%发现淋巴结阳性。
  • 淋巴结清扫与5年无局部区域复发率提高相关(92% vs 74%)。

核心结论

  • 楔形切除同期行淋巴结采样不增加并发症和住院时间,可发现4.3%的阳性淋巴结,并降低局部区域复发,可能带来生存获益。

研究设计与样本

  • 回顾性队列研究,纳入196例接受楔形切除的周围型临床IA期非小细胞肺癌患者,按是否行淋巴结评估分组。
  • 采用Kaplan-Meier法分析生存,log-rank检验比较差异,并以倾向评分匹配控制年龄、性别、Charlson合并症指数、肺叶切除耐受性、手术年份、肿瘤大小和手术入路(每组51例,卡钳值0.2)。

主要发现

  • 196例中138例(70%)行淋巴结清扫(中位4枚),58例(30%)未清扫;两组临床和病理特征无显著差异。
  • 两组手术时间、估计失血量、胸管留置时间和住院时间无差异;中位pT大小均为1.5 cm(P=0.73)。
  • 淋巴结清扫组6例(4.3%)淋巴结阳性。
  • 淋巴结清扫组5年无局部区域复发率高于未清扫组(92% vs 74%,P=0.025)。
  • 倾向评分匹配后,淋巴结清扫组无局部复发概率仍更高(P=0.024)。

关键数值与推荐

  • 淋巴结清扫组中位清扫4枚淋巴结。
  • 淋巴结阳性率为4.3%(6/138)。
  • 5年无局部区域复发率:清扫组92%,未清扫组74%(P=0.025)。
  • 倾向评分匹配后无局部复发差异P=0.024。
  • 两组中位pT大小均为1.5 cm(P=0.73)。

临床怎么用

  • 对接受楔形切除的周围型临床IA期非小细胞肺癌患者,应同期行淋巴结采样/清扫以评估分期。
  • 淋巴结清扫不增加手术时间和住院资源,可安全实施。
  • 淋巴结清扫有助于降低局部区域复发,可能改善生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: For patients undergoing lobectomy for non-small cell lung cancer (NSCLC), a survival benefit exists with increased number of lymph nodes (LNs) resected. We sought to evaluate the associations of LN removal with outcomes in clinical stage I lung cancer patients undergoing wedge resection. METHODS: We evaluated all patients undergoing wedge resection for peripheral, clinical stage IA NSCLC and grouped patients into those with and without LN assessment. Data were compared and survival analysed using Kaplan-Meier, with differences compared using log-rank. Propensity score matching controlling for age, gender, Charlson comorbidity index, patient tolerability of lobectomy, surgery year, tumour size and surgical approach was done (51 patients in each group, caliper 0.2). RESULTS: We identified196 patients undergoing wedge resection, of whom 138 patients (70%) had LNs resected (median = 4 nodes), while the remaining 58 patients (30%) had none. There were no significant differences in the clinical or pathologic characteristics between the two groups. There was no difference in terms of OR time, estimated blood loss, chest tube duration or length of stay. Median pT size was 1.5 cm in each group ( P = 0.73). Among patients with LNs removed, 6 (4.3%) had positive nodes Patients in the LN assessed group had higher probability of freedom from loco-regional recurrence compared to the no lymph node (NLN) group (5-year: 92 vs 74%, P = 0.025).In propensity matched groups, patients who underwent LN dissection also had higher probability of freedom from local recurrence ( P = 0.024). CONCLUSIONS: Accompanying wedge resection for lung cancer, LN sampling adds no morbidity and does not increase length of stay. Positive nodes are identified in 4.3% of patients thought eligible for wedge resection. LN removal appears to decrease locoregional recurrence and may be associated with a survival benefit.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Stiles BM, Kamel MK, Nasar A, et al. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer. Eur J Cardiothorac Surg. 2017. PMID: 28007869. doi:10.1093/ejcts/ezw343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。